EFFECTS OF SELEGILINE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A DOUBLE-BLIND CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FAYAZI BORDBAR M.R.; ABD ELAHIAN E.; HOJAT K.; SAMARI A.A.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Psychiatry and Clinical Psychology Year:2008 | Volume:14 | Issue:2 (53) Page(s): 131-139

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

1,003

Download:

Cites:

Information Journal Paper

Title

EFFECTS OF SELEGILINE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A DOUBLE-BLIND CLINICAL TRIAL

Author(s)

FAYAZI BORDBAR M.R. | ABD ELAHIAN E. | HOJAT K. | SAMARI A.A. | Issue Writer Certificate

Keywords

SELEGILINEQ3

NEGATIVE SYMPTOMSQ3

SCHIZOPHRENIAQ3

Abstract

Objectives: This research was carried out with the aim of examining the effects of SELEGILINE, a monoamine oxidase-B inhibitor with dopaminergic features, on the treatment of patients with SCHIZOPHRENIA with prominent NEGATIVE SYMPTOMS.Method: In a clinical trial, 80 inpatients at the Hejazi Hospital in Meshed, who were diagnosed with SCHIZOPHRENIA based on Diagnostic and Statistical Manual of Mental Disorders-fourth edition-Text Revision (DSM-IV-TR) criteria, and had prominent NEGATIVE SYMPTOMS (a score of over 15 in Positive and Negative Symptom Scale [PANSS]) entered the study. The patients were randomly divided into three groups: Patients receiving 5mg SELEGILINE, patients receiving 10mg SELEGILINE, and those receiving placebo along with an antipsychotic drug. The patients were then followed-up for six weeks using PANSS and Drug Side Effects Test. Data were analyzed using analysis of variance and t-test.Results: Eight patients were excluded from the study due to an increase in psychotic symptoms and four were excluded because of drug side effects. Mean age of patients was 47.6 and the mean duration of hospitalization was 8.9 years. Even though there was an improvement in NEGATIVE SYMPTOMS in both groups receiving SELEGILINE, the difference between the groups receiving SELEGILINE and the group receiving placebo was not significant.Conclusion: SELEGILINE is not superior to placebo in reducing NEGATIVE SYMPTOMS in hospitalized patients.

Cites

No record.

References

No record.

Cite

APA: Copy

FAYAZI BORDBAR, M.R., ABD ELAHIAN, E., HOJAT, K., & SAMARI, A.A.. (2008). EFFECTS OF SELEGILINE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A DOUBLE-BLIND CLINICAL TRIAL. IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 14(2 (53)), 131-139. SID. https://sid.ir/paper/16640/en

Vancouver: Copy

FAYAZI BORDBAR M.R., ABD ELAHIAN E., HOJAT K., SAMARI A.A.. EFFECTS OF SELEGILINE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A DOUBLE-BLIND CLINICAL TRIAL. IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY[Internet]. 2008;14(2 (53)):131-139. Available from: https://sid.ir/paper/16640/en

IEEE: Copy

M.R. FAYAZI BORDBAR, E. ABD ELAHIAN, K. HOJAT, and A.A. SAMARI, “EFFECTS OF SELEGILINE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A DOUBLE-BLIND CLINICAL TRIAL,” IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, vol. 14, no. 2 (53), pp. 131–139, 2008, [Online]. Available: https://sid.ir/paper/16640/en

Related Journal Papers